Top Stories
-
Ten years ago, a Columbia postdoc identified a simple nutrient that can alleviate Parkinson’s disease symptoms in mice by rewiring the brain. It’s finally being put to the test in people.
Topic
-
Established two decades ago, the essential tremor brain bank at Columbia has been instrumental in revealing the source and biology of a common but understudied neurodegenerative disorder.
Topic
-
Variants of the ABCA7 gene accelerate neurodegeneration by reducing the amount of neuropeptide Y, a protein essential for maintaining brain synapses.
Topic
-
Analysis of 1.6 million brain cells from older adults has captured the cellular changes that occur in Alzheimer’s early stages, revealing potential new targets and routes for prevention.
Topic
Latest News
- August 13, 2013
Two Columbia faculty are part of a 61-member international research team that discovered 25 epilepsy-causing mutations in new and previously identified genes.
Topic
- August 9, 2013
Watch all eight talks from TEDMED Day CUMC, now available online.
Topic
- July 24, 2013
Key molecular pathways that lead to Alzheimer's identified—a new approach to Alzheimer’s research; several potential drug targets highlighted.
Topic
- July 11, 2013
In an article in Scientific American’s “Talking Back Blog” published yesterday, writer Gary Stix highlights the work of Columbia’s Dr. Olajide Williams.
Topic
- June 27, 2013
Ottavio Arancio, MD, PhD, of CUMC's Taub Institute, coauthored a paper on a compound that prevents memory loss in a mouse model of Alzheimer's. See Northwestern's news release: http://bit.ly/14Zqwwn
Topic
- June 25, 2013
Mouse study suggests inhibiting protein called caspase-2 might prevent cognitive decline in Alzheimer's
Topic
- June 19, 2013
One in 4 stroke survivors suffer from PTSD symptoms within the 1st year post-event, and 1 in 9 experience chronic PTSD more than a year later - results of a study led by Columbia University Medical Center researchers.
Topic
- May 6, 2013
Columbia University study looks at the relationship between families with exceptional longevity and cognitive impairment consistent with Alzheimer's disease.
Topic
- May 1, 2013
Four research centers including the Center for Stroke Disparities Solutions—a partnership of the New York University Langone Medical Center and Columbia University Medical Center —will develop high-impact culturally tailored interventions aimed at lowering stroke risk among racial and ethnic minorities in the United States.
Topic
- April 17, 2013
Excess glutamate in the brain may spur psychosis in those at risk for schizophrenia, report CUMC investigators in a study published in Neuron.
Topic
